“The FTC Study on Barriers to Entry in the Pharmaceutical Marketplace”
Senate Judiciary Committee
DATE: June 17, 2003
TIME: 10:00 AM
OFFICIAL HEARING NOTICE / WITNESS LIST:
June 10, 2003
NOTICE OF RESCHEDULED HEARING
The hearing scheduled by the Senate Committee on the Judiciary for Tuesday, April 29, 2003 on "The FTC Study on Barriers to Entry in the Pharmaceutical Marketplace," has been rescheduled for Tuesday, June 17, 2003 at 10:00 a.m. in Dirksen Room 226 .
By order of the Chairman
Hearing Before the Committee on the Judiciary
United States Senate
"Legislative and Regulatory Responses to the
FTC Study on Barriers to Entry in the
Tuesday, June 17, 2003
10:00 a.m., 226 Dirksen Senate Office Building
The Honorable Timothy J. Muris, Esq.
Federal Trade Commission
Washington, D. C.
Mr. Dan Troy, Esq.
Chief Counsel for Food and Drugs
Food and Drug Administration
Mr. Sheldon T. Bradshaw, Esq.
Deputy Assistant Attorney General, Office of Legal Counsel
Department of Justice
The Honorable Howard M. Metzenbaum, Esq.
Former United States Senator [D-OH]
Consumer Federation of America
Ms. Kathleen Jaeger, Esq.
President and CEO
Generic Pharmaceutical Association
Mr. Bruce Kuhlik, Esq.
Pharmaceutical Research and Manufacturers of America